Complete Regression of TNBC Tumours and Protective Immunity

• TNBC is a hard-to-treat cancer that is resistant to most chemotherapies. It represents one of many cancer types where a strong clinical need exists for alternatives to current standard of care • Tumour mass was undetectable two weeks after initial treatment and no scarring was evident • There was no recurrence of disease and re-challenge with TNBC implant could not reestablish new tumours, sugge